EUVIMEDEUVIMED entdecken
Crossref

Dongwan Zhike granules attenuate OVA-induced airway inflammation by modulating IL-17 signaling and gut microbiota–EPA metabolic remodeling

Yan Yang, Denglong Sun iD, Chenxuan Wang, Yang Zhan, Xiaoying Cheng, Yanxia Xiong, Yingmeng Li iD

Journal of Pharmacy and Pharmacology · 04.11.2026 · 78 (11)

DOI: 10.1093/jpp/rgag142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 14.11.2026. Verfasst von Yan Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biological Evaluation Research Center, State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, No. 1899…. Hauptthemen laut MEDLINE: Interleukin-17, Drugs, Chinese Herbal, Asthma, Gastrointestinal Microbiome. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Jiangxi Provincial Technology Innovation Guidance Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Asthma is a chronic inflammatory airway disease involving immune dysregulation and epithelial barrier impairment. Dongwan Zhike granules (DW), a multicomponent botanical formulation, exhibits potential anti-inflammatory effects, but its pharmacological mechanisms remain unclear. This study investigated the therapeutic effects and mechanisms of DW in allergic airway inflammation.

Methods

The chemical composition of DW was characterized using a ultra-high-performance liquid chromatography coupled with Q Exactive mass spectrometry (UHPLC–Q Exactive MS). An ovalbumin (OVA)-induced mouse model was established to evaluate airway inflammation. Integrated lung transcriptomics, gut microbiota sequencing, serum metabolomics, and an IL-17A-stimulated airway organoid model were applied to elucidate the underlying mechanisms. Key findings DW alleviated OVA-induced airway pathological injury and inflammatory cell infiltration. Transcriptomic analysis revealed that DW suppressed interleukin-17 (IL-17) signaling-related genes, including Cxcl1, Cxcl2, Mmp13, S100a8, and S100a9. Multiomics analysis revealed that DW treatment was associated with gut microbial remodeling and alterations in eicosapentaenoic acid (EPA)-related lipid metabolism. In airway organoids, DW and EPA reduced IL-1β, IL-6, and TNF-α production and preserved ZO-1 expression, supporting EPA as a candidate metabolic mediator associated with the effects of DW.

Conclusions

DW attenuates airway inflammation through modulation of IL-17-associated inflammatory responses, accompanied by alterations in gut microbial composition and EPA-related lipid metabolism. These findings provide preclinical evidence supporting further investigation of DW in allergic airway inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-17Drugs, Chinese HerbalAsthmaGastrointestinal MicrobiomeEicosapentaenoic AcidAnti-Inflammatory AgentsAnimalsOvalbuminSignal TransductionMiceDisease Models, AnimalLungMice, Inbred BALB CFemaleInflammationLipid Metabolism

Stichwörter der Autor:innen

Dongwan Zhike granulesEPAIL-17 signaling pathwayairway inflammationasthmagut–lung axis

Substanzen

Interleukin-17Drugs, Chinese HerbalOvalbuminEicosapentaenoic AcidAnti-Inflammatory AgentsIl17a protein, mouse

Autor:innen und Institutionen

  • Biological Evaluation Research Center, State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, No. 1899 Meiling Avenue, Nanchang, China.
  • State Key Laboratory (Institute of Traditional Chinese Medicine), China Resources Jiangzhong Pharmaceutical Co., Ltd., No. 1899 Meiling Avenue, Nanchang, China.

ORCID-Profile: Denglong Sun, Yingmeng Li

Förderung

  • Jiangxi Provincial Technology Innovation Guidance Program

Zitieren

APA

Yang, Y., Sun, D., Wang, C., Zhan, Y., Cheng, X., Xiong, Y., & Li, Y. (2026). Dongwan Zhike granules attenuate OVA-induced airway inflammation by modulating IL-17 signaling and gut microbiota–EPA metabolic remodeling. Journal of Pharmacy and Pharmacology, 78(11). https://doi.org/10.1093/jpp/rgag142

Vancouver

Yang Y, Sun D, Wang C, Zhan Y, Cheng X, Xiong Y, et al. Dongwan Zhike granules attenuate OVA-induced airway inflammation by modulating IL-17 signaling and gut microbiota–EPA metabolic remodeling. Journal of Pharmacy and Pharmacology. 2026;78(11). doi:10.1093/jpp/rgag142

BibTeX
@article{Yang2026,
  author = {Yang, Yan and Sun, Denglong and Wang, Chenxuan and Zhan, Yang and Cheng, Xiaoying and Xiong, Yanxia and Li, Yingmeng},
  title = {Dongwan Zhike granules attenuate OVA-induced airway inflammation by modulating IL-17 signaling and gut microbiota–EPA metabolic remodeling},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2026},
  volume = {78},
  number = {11},
  doi = {10.1093/jpp/rgag142}
}
Kostenlos starten →